Description: The purpose of this SOA-sponsored research was to assemble and analyze a limited large claims database which may serve as a model for expanded inter-company studies of health care benefits in the future. From Group Medical Insurance Large Claims Database Collection and Analysis, M-HB97-1.

Description: Chapter 1 presents the background to the current study, followed by the methodology used, and a summary of the findings of the study. From Group Medical Insurance Large Claims Database Collection and Analysis, M-HB97-1.

Description: This is an Impairment Study Capture System (ISCS) study of contemporary Diabetes Mellitus mortality among insured lives. The policies were issued at standard or substandard premium rates between 1989 and 2002 policy anniversaries.

Description: This study used the Impairment Study Capture System (ISCS) to examine mortality results of policies, beginning in 1989, on insured lives with elevated blood pressure.

Description: Results of survey conducted in July 2006 about the methods used by insurers to develop their pricing mortality assumptions for fully underwritten life insurance in the U.S. The objective was to understand how companies adjust base mortality tables and whether mortality improvement was assumed.

Description: The 2013 Individual Disability Income Valuation Table (2013 IDIVT) approved by the NAIC as the new statutory minimum reserve morbidity basis.

Description: The Committee's charge was to develop new disability tables for possible adoption by appropriate authorities for valuation of individual policy reserves, i.e. active life reserves, and individual and group claim reserves for disabled lives. It was generally agreed that the current valuation table, the 1964 Commissioner’s Disability Table, ‘1964 CDT,’ was no longer appropriate for several reasons. This paper presents the detailed results of the committee's findings and their recommendations. From the 1985 Transactions, Vol. 37.

Description: A report on the results of the latest intercompany study of mortality experience under structured settlement annuities for the exposure years 2009-13.

Description: Critical illness CI products are gaining in popularity in North America. These products have been available for close to 20 years in many countries around the world, including South Africa, Australia, the United Kingdom and most of Asia. Many of the lessons learned in these countries concerning product design, pricing, underwriting and claims adjudication are relevant to the U.S. market. This session reviews the latest trends around the world. Attendees gain insight into the key issues driving the profitability of the product and are better positioned to determine the main considerations in deciding whether or not to introduce such a product in their market. From the Record of the Society of Actuaries, Volume 29, No. 1, Washington, D.C., Spring Meeting, May 29–30, 2003, Session 60PD.

Description: This session explores current practices and techniques that plan sponsors use to address the risks associated with the exercise of fiduciary responsibility. Attendees gain a better understanding of some of the issues that plan sponsors face and discuss the tools that can be used to monitor and manage exposure to risks and uncertainty. From the Record of the Society of Actuaries, Volume 29, No. 2: Spring Meeting, Vancouver, B.C., June 23–25, 2003, Session 108PD.